rs664677
A SNP in the ATM gene on chromosome 11. Its most notable genotype is C;C: Lower lung cancer and increased breast cancer risk
- Gene
- ATM
- Location
- Chr 11108,272,455 (GRCh38)
- Highest magnitude
- 2.1Worth knowing
- Tested on
- 23andMe, AncestryDNA
- Minor allele frequency
- 39%
Genotypes
As shown in 23andMe and AncestryDNA files.
- C;CMost notableNot ratedLower lung cancer and increased breast cancer risk
- C;TNot ratedLower lung cancer and increased breast cancer risk
On SNPedia: (C;C), (C;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 11 HapMap populations.
- AverageC;C 18% C;T 42%
- European ancestry (Utah)C;C 20% C;T 53%
- Han Chinese (Beijing)C;C 36% C;T 44%
- Japanese (Tokyo)C;C 42% C;T 41%
- Yoruba (Nigeria)C;C 3% C;T 35%
- African ancestry (Southwest US)C;C 5% C;T 26%
- Chinese (Denver)C;C 32% C;T 50%
- Gujarati IndianC;C 10% C;T 39%
- Luhya (Kenya)C;C 6% C;T 39%
- Mexican ancestry (Los Angeles)C;C 21% C;T 43%
- Maasai (Kenya)C;C 15% C;T 54%
- TuscanC;C 12% C;T 33%
Related
Conditions, medicines and genes
Other ATM SNPs
- rs147557621G;TBreast cancer associated mutationVery important
- rs200976093C;TBreast cancer associated mutationVery important
- rs376170600C;GBreast cancer associated mutationVery important
- rs376603775C;TBreast cancer associated mutationVery important
- rs529296539C;GBreast cancer associated mutationVery important
- rs587776551A;GBreast cancer associated mutationVery important
- rs587778080C;TBreast cancer associated mutationVery important
- rs587779813A;GBreast cancer associated mutationVery important
Notes
From SNPedia
Show notes, about 170 words
Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes. Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. ATM polymorphisms and risk of lung cancer among never smokers.
C;C
rs664677 polymorphism was associated with decreased lung cancer risk and increased breast cancer risk (for lung cancer: TC vs. TT: OR = 0.76, 95% CI 0.62-0.92, CC vs. TT: OR = 0.80, 95% CI 0.64-0.99 and for breast cancer: TC vs. TT: OR = 1.42, 95% CI 1.17-1.73, CC vs. TT: OR = 1.51, 95% CI 1.21-1.87). PMID 22203481
C;T
rs664677 polymorphism was associated with decreased lung cancer risk and increased breast cancer risk (for lung cancer: TC vs. TT: OR = 0.76, 95% CI 0.62-0.92, CC vs. TT: OR = 0.80, 95% CI 0.64-0.99 and for breast cancer: TC vs. TT: OR = 1.42, 95% CI 1.17-1.73, CC vs. TT: OR = 1.51, 95% CI 1.21-1.87). PMID 22203481
References
Source and license
Adapted from rs664677 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.